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Abstract
Background: Sand fly saliva has an array of pharmacological and immunomodulatory components, and immunity to saliva
protects against Leishmania infection. In the present study, we have studied the immune response against Lutzomyia
intermedia saliva, the main vector of Leishmania braziliensis in Brazil, and the effects of saliva pre-exposure on L. braziliensis
infection employing an intradermal experimental model.
Methodology/principal findings: BALB/c mice immunized with L. intermedia salivary gland sonicate (SGS) developed
a saliva-specific antibody response and a cellular immune response with presence of both IFN-c and IL-4. The inflammatory
infiltrate observed in SGS-immunized mice was comprised of numerous polymorphonuclear and few mononuclear cells.
Mice challenged with live L. braziliensis in the presence of saliva were not protected although lesion development was
delayed. The inoculation site and draining lymph node showed continuous parasite replication and low IFN-c to IL-4 ratio,
indicating that pre-exposure to L. intermedia saliva leads to modulation of the immune response. Furthermore, in an
endemic area of cutaneous leishmaniasis, patients with active lesions displayed higher levels of anti-L. intermedia saliva
antibodies when compared to individuals with a positive skin test result for Leishmania.
Conclusion: These results show that pre-exposure to sand fly saliva plays an important role in the outcome of cutaneous
leishmaniasis, in both mice and humans. They emphasize possible hurdles in the development of vaccines based on sand fly
saliva and the need to identify and select the individual salivary candidates instead of using whole salivary mixture that may
favor a non-protective response.
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Introduction
Protozoan parasites of the genus Leishmania cause a broad
spectrum of diseases, collectively known as leishmaniasis, that
occur predominantly in tropical and subtropical regions. The
leishmaniases are transmitted by different species of sand flies, and
depending on the Leishmania species involved and the genetic
makeup or immunological status of the host, different clinical
manifestations of the disease are observed.
The mammalian host acquires leishmaniasis when it is bitten by
an infected sand fly vector. During parasite inoculation, the host is
also injected with the sand fly saliva which has been shown to
contain a repertoire of bio-active molecules capable of interfering
with the host’s hemostatic, inflammatory and immune responses
(reviewed in [1,2,3]). Among the latter, it has been shown that
sand fly saliva can exert a direct effect upon the function of
cells from the immune system [4,5,6]. In fact, it was shown early
on that co-inoculation of L. longipalpis or P. papatasi salivary
gland sonicate (SGS) and L. major led to a significant exacerbation
of lesion size and parasite load in BALB/c mice [7,8]. Similar
effects were observed with L. braziliensis [9,10] and L. amazonensis
[11].
On the other hand, mice are protected against L. major when
immunized with SGS [8], when pre-exposed to the bites of
uninfected sand flies [12] or, more recently, when immunized with
saliva components [13,14]. Since the composition of salivary
molecules, their function and antigenicity varies among distinct
sand fly species [15,16,17] it is of foremost importance to
investigate whether vector-based vaccines can also be developed
against other Leishmania species. American cutaneous leishmania-
sis, caused by Leishmania braziliensis, is distinguished from other
leishmaniases by its chronicity, latency and tendency to metasta-
size in the human host leading to muco-cutaneous leishmaniasis
[18,19]. In this sense, we have, in the present report, investigated
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vector of L. braziliensis in Brazil, (b) the effect of vaccination with L.
intermedia saliva followed by challenge with L. braziliensis plus saliva
and c) anti-saliva immune response of individuals from an endemic
area of cutaneous leishmaniasis. In order to do so, we employed
a recently developed experimental model of cutaneous leishman-
iasis (CL), based upon the inoculation of L. braziliensis parasites into
the dermis of BALB/c mice [20].
Materials and Methods
Mice
Female BALB/c mice (6–8 weeks of age) were obtained from
CPqGM/FIOCRUZ Animal Facility where they were maintained
under pathogen-free conditions. All procedures involving animals
were approved by the local Ethics Committee on Animal Care and
Utilization (CEUA - CPqGM/FIOCRUZ).
Sand Flies and Preparation of SGS
Lutzomyia intermedia, Corte de Pedra strain, and Lutzomyia
longipalpis, Cavunge strain, were reared at Centro de Pesquisas
Gonc ¸alo Moniz-FIOCRUZ, as described elsewhere [21]. Adult
sand flies were used for dissection of salivary glands at 3–5 days
after emergence. Salivary glands were stored in groups of 20 pairs
in 20 ml NaCl (150 mM) Hepes buffer (10 mM, pH 7.4), at
270uC. Immediately before use, salivary glands were disrupted by
ultrasonication within 1.5 ml conical tubes. Tubes were centri-
fuged at 10,0006g for 2 min and the resultant supernatant
(Salivary Gland Sonicate - SGS) was used for the studies. The level
of LPS contamination of SGS preparations was determined using
a commercially available LAL Chromogenic Kit (QCL-1000,
Lonza Bioscience); LPS concentration was ,0.1 ng/ml and SGS
did not stimulate human monocytes. In order to evaluate the
immunogenic potential of L. intermedia saliva, BALB/c mice were
immunized three times with SGS (equivalent to 1 pair of salivary
glands) in 10 ml of PBS, in the dermis of the right ear, using
a 27.5 G needle. Immunizations were performed at 2 week
intervals. Control mice were injected with PBS.
Analysis of anti-saliva antibodies by ELISA and Western
blot
ELISA microplates were coated overnight at 4uC with 50 ml
SGS diluted to 5 pairs of salivary glands/ml in coating buffer
(NaHCO3 0.45 M, Na2CO3 0.02 M, pH 9.6). After washing with
PBS-Tween, wells were blocked with PBS-Tween plus 5% dried
skim milk for 1 hour at 37uC. Wells were incubated overnight with
sera from control or immunized mice, obtained two weeks after
the last immunization, diluted (1:50) in PBS-Tween. After further
washings, wells were incubated with alkaline phosphatase-
conjugated anti mouse IgG antibody (Promega) diluted (1:5000)
in PBS-Tween, for 1 hour at 37uC. Following another washing
cycle, wells were developed with p-nitrophenylphosphate in
sodium carbonate buffer pH9.6 with 1 mg/ml of MgCl2. The
absorbance was recorded at 405 nm. Serum IgG subclasses were
determined using anti–mouse IgG1, IgG2a or IgG2b alkaline-
phosphatase conjugates (Sigma). To check that anti-IgG1, anti-
IgG2a and anti-IgG2b were working properly, purified mouse
IgG1 (clone CD28.2 [2 mg/mL]); mouse IgG2a (clone HIT3a
[2 mg/mL]) and mouse IgG2b (clone G265-5 [2 mg/mL]), all from
BD Pharmingen) were employed as positive controls. SDS-PAGE
and Western blot of L. intermedia and L. longipalpis SGS was
performed as described elsewhere [14]. Briefly, SDS-PAGE was
performed by electrophoresis of SGS equivalent to 20 pairs of L.
intermedia salivary glands (,10 ug of protein) and SGS equivalent
to 10 pairs of L. longipalpis salivary glands (,10 ug of protein) in
Bis-tris gels (4–12%, 1.0 mm) (Invitrogen). After transfer to
nitrocellulose, the membrane was cut into strips, blocked overnight
with blocking buffer (Tris HCl pH 8.0 NaCl 150 mM plus 5%
non-fat milk), then incubated with mouse immune serum (1:50
dilution) in blocking buffer, followed by the anti-mouse IgG
alkaline phosphatase conjugate (1:5000) (Promega). Alternatively,
SDS-PAGE of L. intermedia SGS (100 pairs of L. intermedia salivary
glands or ,50 ug of protein) was performed on Bis-tris gels (4–
12%, 1.0 mm62D) (Invitrogen). After transfer to nitrocellulose,
the membrane was blocked as above, incubated with human sera
(1:50 dilution), followed by the anti-human IgG alkaline
phosphatase conjugate (1:1000) (Sigma). Bands were visualized
by adding alkaline phosphatase substrate (Promega).
Analysis of the inflammatory immune response in the ear
dermis
Following three intra-dermal inoculations with PBS or L.
intermedia SGS in the right ear dermis, mice received a challenge
injection with SGS (equivalent to 1 pair of salivary glands) in the
left ear dermis. Twenty-four hours later, challenged ears were
removed and fixed in 10% formaldehyde. Following fixation,
tissues were processed, embedded in paraffin and 5 mm sections
were stained with hematoxylin and eosin (H & E) and analyzed by
light microscopy.
Intracellular cytokine detection by flow cytometry
Reagents for staining cell surface markers and intracellular
cytokines were purchased from BD Biosciences, San Diego, CA.
Measurement of in vitro cytokine production was performed as
described in de Moura et al. [20]. Briefly, cells were activated in
the presence of anti-CD3 (10 mg/ml) and anti-CD28 (10 mg/ml)
and were later incubated with Brefeldin A (Sigma) (10 mg/ml).
Cells were blocked with anti-Fc receptor antibody (2.4G2) and
were double stained, simultaneously, with anti-mouse surface CD4
(L3T4) and CD8 (53-6.7) conjugated to FITC and Cy-Chrome,
respectively. For intracellular staining of cytokines, cells were
permeabilized using Cytofix/Cytoperm (BD Biosciences) and were
Author Summary
Parasites of the genus Leishmania cause a variety of
diseases known as leishmaniasis, that are transmitted by
bites of female sand flies that, during blood-feeding, inject
humans with parasites and saliva. It was shown that, in
mice, immunity to sand-fly saliva is able to protect against
the development of leishmaniasis. We have investigated,
in the present study, whether this finding extends the sand
fly species Lutzomyia intermedia, which is responsible for
transmission of Leishmania braziliensis, a parasite species
able to cause destructive skin lesions that can be fatal if
left untreated. We observed that mice injected with sand
fly saliva develop a specific immune response against
salivary proteins. Most importantly, however, this immune
response was unable to protect mice against a challenge
infection with L. braziliensis, indicating that exposure to
this sand fly saliva is harmful to the host. Indeed, subjects
with cutaneous leishmaniasis have a higher immune
response against L. intermedia saliva. These findings
indicate that the anti-saliva immune response to sand fly
saliva plays an important role in the outcome of
leishmaniasis caused by L. braziliensis, in both mice and
humans, and emphasize possible hurdles in the develop-
ment of vaccines based on sand fly saliva.
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IFN-c (XMG1.2), IL-4 (BVD4-1D11), and IL-10 (JES5-16E3).
The isotype controls used were rat IgG2b (A95-1) and rat IgG2a
(R35-95). Data were collected and analyzed using CELLQuest
software and a FACSort flow cytometer (Becton Dickinson
Immunocytometry System). The steady-state frequencies of
cytokine positive cells were determined using lymph node cells
from PBS-inoculated mice.
Parasite culture, intradermal inoculation and lesion
measurement
L. braziliensis promastigotes (strain MHOM/BR/01/BA788
[20]) were grown in Schneider medium (Sigma) supplemented
with 100 U/ml of penicillin, 100 ug/ml of streptomycin, 10%
heat-inactivated fetal calf serum (all from Invitrogen) and 2%
sterile human urine. Two weeks following the last immunization
with L. intermedia SGS, mice were challenged in the left ear dermis
by inoculation of stationary-phase promastigotes (10
5 parasites in
10 ml of saline)+SGS (equivalent to 1 pair of salivary glands).
Lesion size was monitored weekly, for 16 weeks, using a digital
calliper (Thomas Scientific).
Parasite load estimate
Parasite load was determined using a quantitative limiting-
dilution assay as described [22]. Briefly, infected ears and
retromaxillar draining lymph nodes (LNs) were aseptically excised
at two, four and 16 weeks post infection and homogenized in
Schneider medium (Sigma). The homogenates were serially
diluted in Schneider medium supplemented as before and seeded
into 96-well plates containing biphasic blood agar (Novy-Nicolle-
McNeal) medium. The number of viable parasites was determined
from the highest dilution at which promastigotes could be grown
out after up to two weeks of incubation at 25uC.
Cytokine detection by ELISA
For measurement of in vitro cytokine production, single-cell
suspensions of draining lymph nodes were prepared aseptically at
two, four and 16 weeks post infection. The cells were diluted to
5610
6 cells/ml in RPMI 1640 supplemented with 2 mM L-
glutamine, 100 U/ml of penicillin, 100 ug/ml of streptomycin,
10% fetal calf serum (all from Invitrogen) and 0.05 M 2-ME and
dispensed into 96-well plates with L. braziliensis (ratio 1:5,
parasite:cells)+L. intermedia SGS (equivalent to 2.5 pair of salivary
glands/ml) or L. intermedia SGS (equivalent to 2.5 pair of salivary
glands/ml) alone. Cultures were incubated at 37uCi n5 %C O 2.
Supernatants were harvested at 48 h and assayed for IL-4 or at
72 h and assayed for IFN-c. Cytokine presence was determined by
ELISA using commercial kits (BD Biosciences).
Study population
Human sera used in the present study were obtained from an
epidemiological survey conducted in a region endemic for
American cutaneous leishmaniasis (Canoa, a rural village, located
near Santo Amaro, Bahia, Brazil). Details of the area, patients and
anti-Leishmania (Delayed Type Hypersensitivity) DTH skin test are
described elsewhere [23]. Informed consent was obtained from
patients or their guardians and all procedures were approved by
the local Ethics Committee (CEP/MCO/UFA) and were
conducted following recommendations outlined in the Helsinki
Declaration. Briefly, after an outbreak of cutaneous leishmaniasis
(CL) in Canoa, three groups of individuals were characterized: 1)
Patients who developed CL; 2) Individuals who converted the
DTH skin test to Leishmania antigen and who did not develop
disease and 3) Individuals who had a negative anti-Leishmania
DTH skin test. ELISA for detection of anti-saliva antibodies in
these three groups was performed as described in [24]. Control
sera were obtained from individuals residing in Salvador, BA, an
area not endemic for leishmaniasis. These individuals showed
negative responses to both anti-Leishmania sorology and anti-
Leishmania DTH skin test. ELISA was performed as above. Briefly,
microplates were coated with SGS diluted to 5 pairs of salivary
glands/ml in coating buffer, wells were blocked, incubated
overnight with human sera (1:50 dilution), followed by alkaline
phosphatase-conjugated anti-human IgG (1:5000 dilution) .
Statistical analysis
Data are presented as mean6standard error of the mean. The
significance of the results was calculated by Mann Whitney or
Kruskal-Wallis tests using Prism (Graph Pad Software) and P-
values ,0.05 were considered significant. To evaluate disease
burden in mice, ear thickness of mice immunized with SGS and
challenged with SGS+L. braziliensis was recorded weekly, for each
individual mouse. The course of disease for experimental and
control mice was plotted individually and the area under each
resulting curve was calculated using Prism (Graph Pad Software).
The significance of the results (area under curve obtained for each
mouse immunized with SGS versus area under curve obtained for
each mouse immunized with PBS) was calculated by Mann
Whitney. In studies performed with human sera, significance of
the results was calculated by Kruskal Wallis test followed by
Bonferroni’s Multiple Comparison Test.
Results
Immune response in L. intermedia saliva immunized
BALB/c mice
Sera from immunized mice obtained two weeks after the last
immunization were able to recognize L. intermedia SGS by ELISA
(Fig. 1A) and, importantly, the presence of IgG1 was significantly
higher in mice L. intermedia SGS-immunized when compared to
PBS-immunized mice. Similar differences were not observed when
we compared IgG2a and IgG2b levels in SGS and PBS-
immunized mice (Fig. 1B). Western blot confirmed that immune
sera specifically recognized the majority of bands seen in L.
intermedia SDS-PAGE profiles (Fig. 1D and 1C, respectively).
When L. intermedia SGS immune sera were probed against L.
longipalpis SGS, the only protein recognized was a protein of
approximately 45 kDa, a protein with similar mobility to the
yellow related protein from L. longipalpis (Fig. 1D).We can
speculate that, although the salivary gland protein profiles of both
sand fly species appear similar (Fig. 1C), their antigenic properties
are different (Fig. 1D).
A mixed cytokine response, with the presence of both IFN-c and
IL-4 was observed in immunized animals (Fig. 2A). These
cytokines were detected within CD4+ (left panel) and CD8+ T
cells (right panel), at comparable levels. IL-10 expression was also
detected in these two cell populations, albeit in a lower frequency
when compared to IFN-c and IL-4.
L. intermedia SGS also induced an important inflam-
matory response in immunized mice. Injection of SGS follow-
ing immunization with SGS elicited, at 24 h post SGS
injection, an inflammatory infiltrate comprised of numerous
polymorphonuclears (PMNs) and few mononuclear cells (Fig. 3A
and B). Edema and vascular congestion were also noted. At 48 h
post challenge injection with SGS, the infiltrate was more
pronounced, with higher numbers of PMNs and mononuclear
cells and accentuated myositis (not shown). In mice which received
Immune Modulation by Sandfly Saliva
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formation with rare inflammatory cells at 24 h (Fig. 3C and D).
This effect was decreased at 48 h (data not shown).
L. braziliensis infection in L. intermedia-saliva immunized
mice
We then examined whether immunization with L. intermedia
saliva altered the course of L. braziliensis infection in BALB/c mice,
using an intradermal experimental model of infection [20].
Surprisingly, pre-immunization with L. intermedia SGS did not
protect against lesion development. As shown in Fig. 4A, the onset
of lesion development in PBS-inoculated mice was at three weeks
post infection, peaking at five weeks and resolving, spontaneously,
by returning to normal ear thickness after ten weeks. In L.
intermedia SGS immunized mice, however, dermal lesions appeared
later, at five weeks post infection and peaked at eight weeks post
infection (Fig. 4A). From then on, lesions slowly declined and
resolved at 16 weeks post infection, although ear thickness never
returned to normal levels (0.2–0.3 mm). No significant differences
in ear thickness, between both groups, were observed throughout
infection. However, two weeks following infection, SGS–immu-
nized mice showed a slight inflammatory infiltrate with a discrete
increase in PMNs (data not shown). Importantly, a significant
difference (p,0.05) was observed when we evaluated disease
burden in SGS and PBS-immunized mice (Fig. 4B). Disease
burden was calculated by weekly measure of ear thickness and by
comparison of the area under the resulting curves, as explained
under statistical analysis. As shown in Fig. 4B, dermal lesions
persisted for a longer period of time in SGS-immunized mice
indicating that disease burden is more pronounced in these mice
when compared to PBS-immunized mice.
Parasite load in the ear dermis and draining lymph nodes
of L. intermedia saliva immunized mice challenged with L.
braziliensis
We then examined whether there was a correlation between
lesion development and parasite replication in L. intermedia saliva
immunized mice. As shown in Fig. 5, two weeks after challenge,
parasite load in the ear dermis and draining lymph nodes was
significantly lower in saliva immunized mice (Fig. 5A and B). Four
weeks after challenge, parasite load was similar in both groups of
animals, in the two compartments analyzed, which correlated with
the similar lesion sizes (Fig.4A). Later, 16 weeks following
challenge, mice immunized with L. intermedia SGS displayed
a significantly higher parasite load in the ear (Fig. 5A) whereas no
significant differences were observed in the draining lymph nodes
of both groups (Fig. 5B). At this same time point, however, there
was no significant difference in ear thickness in both groups of
mice.
Immune response in L. intermedia saliva immunized mice
challenged with L. braziliensis
Next, we examined the immune response in mice immunized
with L. intermedia saliva and challenged with L. braziliensis plus SGS.
Two weeks following infection, the IFN-c to IL-4 ratio is two-fold
higher in animals inoculated with PBS when compared to mice
immunized with SGS (Fig. 6). This higher IFN-c production in
relation to IL-4 was observed following in vitro stimulation with
either L. braziliensis+SGS (Fig. 6A) or SGS alone (Fig. 6B). Later
on, the IFN-c to IL-4 ratio in PBS inoculated mice, decreased
steadily, correlating with the decrease in ear thickness (Fig. 4A)
and in parasitemia at the inoculation site (Fig. 5A). Overall, SGS
Figure 1. Anti-saliva antibody response following immuniza-
tion of BALB/c mice with Lutzomyia intermedia SGS. BALB/c mice
(3–5 per group) received 3 inoculations of PBS (open bars) or SGS (closed
bars). (A) ELISA was performed with sera from mice inoculated with PBS
(open bars) or SGS (closed bars). (B) IgG subclasses present in immune
sera were determined by ELISA using IgG1, IgG2a and IgG2b conjugates.
Purified IgG1, IgG2a and IgG2b (dotted bars) were employed as control
IgG subclass (positive controls). Bars represent the means and standard
errors of the means from three independent experiments (*p,0.05). (C)
Commassie blue-stained SDS-PAGE gel after electrophoresis of L.
intermedia (L.int) and L. longipalpis (L.lon) SGS. The numbers represent
the position of the mol wt markers. (D) Western blots of the gels showed
in C, probed with sera from L. intermedia SGS immunized mice.
doi:10.1371/journal.pntd.0000084.g001
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after stimulation with either Leishmania plus SGS or after
stimulation with SGS alone, which can be correlated with the
higher disease burden (Fig. 4B) and the constant increase in
parasite load (Fig. 5A).
Humoral immune response against L. intermedia saliva in
an endemic area for Cutaneous Leishmaniasis
Data obtained in mice immunized with L. intermedia saliva and
later challenged with L. braziliensis showed that, in this case, saliva
immunization failed to protect against a challenge infection with L.
braziliensis. Although immunization with L. intermedia saliva delayed
lesion appearance, lesions persisted for longer periods when
compared to PBS inoculated mice. Upon this finding, we then
asked whether human antibody response to L. intermedia saliva
could be used to monitor exposure to sand fly and, possibly, be
used as a marker of disease. In order to do so, we first investigated
the anti-L. intermedia humoral immune response in individuals
living in an endemic area for cutaneous leishmaniasis (CL). As
shown in Fig. 7A, CL endemic area individuals possessed
significantly higher anti-L. intermedia SGS IgG levels when
compared to control sera (sera obtained from individuals residing
in a non-endemic area). When sera from a CL endemic area were
Figure 2. Intracellular cytokine production by CD4 and CD8 T cells following immunization of BALB/c mice with Lutzomyia
intermedia SGS. BALB/c mice (3–5 per group) received 3 inoculations of PBS (open bars) or SGS (closed bars). Fifteen days after the last inoculation,
draining lymph nodes were pooled and cells were preincubated with Brefeldin A for four hours before being stained. Data represent the percentages
of cells with signals for the particular cytokine that were greater than the background signals established using isotype controls. Bars represent the
means and standard errors of the means of one experiment, representative of three independent experiments.
doi:10.1371/journal.pntd.0000084.g002
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lower when compared to IgG levels against L. intermedia SGS,
illustrating the specificity of the anti-saliva immune response. We
then selected, among individuals from the endemic area with
positive anti-L. intermedia SGS IgG response (Fig. 7A), a subgroup
of patients with active lesion at the time of serum collection (CL),
a subgroup of individuals with positive anti-Leishmania DTH skin
test and a subgroup with negative DTH skin test. Sera from these
three subgroups were again probed against L. intermedia SGS. As
shown in Fig. 7B, CL patients displayed a significantly higher IgG
immune response against saliva when compared to individuals
with positive DTH. This was also observed when comparing CL
patients and DTH negative individuals. These results show that
humoral immune response to L. intermedia SGS is a marker of
disease in CL. Western blot analysis (Fig. 8) showed that sera from
CL individuals displayed the strongest response against L. intermedia
SGS, when compared to DTH2 and DTH+ individuals. This
strong response was observed particularly for the 62 kD, 49 kD,
45 kD, 36 Kd, 28 kD and 14 kD bands. Sera from DTH2
individuals, on the other hand, recognized, preferentially, the
28 kD and, in some cases, the 14 kD and 36 kD bands. Last, sera
from DTH+ individuals showed the weakest response, when
compared to CL and DTH2 individuals. Nonetheless, these sera
were able to detect, for some individuals, the 45 kD, 36 kD and
28 kD bands. Sera from controls individuals (-) did not recognize
any of the salivary proteins.
Discussion
The results presented herein show that L. intermedia SGS shifted
the immune responses to L. braziliensis to type 2 and immunization
of BALB/c mice with SGS led to enhanced L. braziliensis infection.
Additionally, induction of this distinctive role played by L.
intermedia saliva comes from data obtained with patients with
active CL who presented higher anti-L. intermedia SGS antibody
titers when compared to exposed individuals with positive anti-
Leishmania DTH.
Initially, we investigated the immunogenic properties of L.
intermedia, the main vector of L. braziliensis in Brazil. We observed
that mice immunized with L. intermedia SGS developed a specific
Figure 3. Histological aspects in animals immunized with L. intermedia SGS. Mice received three inoculations with SGS (A and B) or PBS (C
and D). Two weeks after the last inoculation, mice received a challenge with SGS in the contra-lateral ear. Tissue sections were obtained 24 h after
challenge and stained with hematoxylin and eosin and analyzed under a light microscope. Magnifications are 640 (A and C) and 6200 (B and D).
doi:10.1371/journal.pntd.0000084.g003
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The main subclass present in immune sera was IgG1. In the
absence of IgG2a, this is indicative of a preferential type 2 immune
response, knowingly associated with susceptibility to leishmaniasis
(revised in [25]. The presence of IgG1 was also observed upon
natural exposure of mice to L. longipalpis bites [5] and upon
immunization with P. ariasi SGS [26]. In an area endemic for
visceral leishmaniasis, exposed individuals showed a mixed
composition of IgG1 and IgE antibodies to L. longipalpis saliva,
suggesting a mixed type1/type 2 response [27]. This type of
response has also been detected herein as shown by the presence of
both IFN-c and IL-4 in cell culture supernatants from L. intermedia
SGS immunized mice.
Specificity of the humoral immune response was tested by
probing immune sera with L. longipalpis SGS, this species being the
vector of L. chagasi, the causative agent of American visceral
leishmaniasis. Interestingly, SDS-PAGE profiles of salivary
proteins from both sand flies showed bands migrating at similar
molecular weights. However, L. intermedia immune sera did not
recognize any proteins present in L. longipalpis SGS with the
exception of the ,45 kDa protein. The species-specificity of sand
fly salivary gland components has been examined elsewhere
[28,29]. Thiakaki et al. [30] showed that mice exposed to bites of
three sand fly species developed antibodies specific to the different
saliva antigens, indicating the specificity of anti-saliva immune
responses. Indeed, results from our laboratory have shown that
salivary content similarity between L. intermedia and L. longipalpis is
low (de Oliveira et al., manuscript in preparation) corroborating
the lack of antibody of cross-reactivity and emphasizing the
uniqueness of the sand fly saliva antigens.
Surprisingly, immunization with L. intermedia SGS did not confer
any protection against L. braziliensis development: SGS immunized
mice developed larger lesions which were maintained for a longer
period when compared to PBS inoculated mice. As observed
before in L. braziliensis infected mice [20], parasites were able to
Figure 4. Lesion development in L. intermedia SGS immunized
BALB/c mice following infection with L. braziliensis+SGS. BALB/c
mice (3–5 per group) were inoculated three times in the right ear with L.
intermedia SGS (closed bars) or with PBS (open bars) and were challenged
intheleftearwithL.braziliensisplusL.intermediaSGS(equivalentto1pair
of salivary gland). (A) The course of lesion development was monitored
weekly and bars represent the means and standard errors of the means
from three independent experiments. (B) Disease burden in mice
inoculated with PBS or SGS and challenged with SGS+L. braziliensis.T h e
areas contained underneath the curves obtained in (A) for each
experimental and control mouse were compared. (*p,0.05).
doi:10.1371/journal.pntd.0000084.g004
Figure 5. Parasite load estimate in BALB/c mice immunized
with L. intermedia SGS or PBS and challenged with L. braziliensis
in the presence of L. intermedia SGS. BALB/c mice (3–5 per group)
were inoculated three times with PBS (open bars) or SGS (closed bars).
Two weeks after the last inoculation, mice were challenged with 10
5 L.
braziliensis+SGS (equivalent to 1 pair of salivary glands/animal). Ear (A)
and draining lymph node (B) parasite loads were determined at two,
four and 16 weeks post infection via a limiting dilution assay. Bars
represent the means and standard errors of the means from three
independent experiments. (*p,0.05)
doi:10.1371/journal.pntd.0000084.g005
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lack of protection against a challenge infection in SGS immunized
mice can therefore be correlated with the low IFN-c to IL-4 ratio
observed throughout the infection period, an effect not observed in
PBS inoculated mice. In the latter, disease burden was significantly
lower, indicating their ability to mount and sustain a balanced
immune response. Initially, SGS immunized mice showed
a significantly lower parasite burden after challenge with parasites
plus saliva. It is possible that this early control in parasitemia may
be exerted by inflammatory cells (mono and polymorphonuclear
cells) that are recruited following stimulation with saliva. This early
control, however is not maintained since parasite multiplication
was clearly observed, probably as a result of the pathogen-
favorable adaptative immune response that is developed in SGS
immunized mice. It has been shown that macrophages phagocy-
tose apoptotic neutrophils infected with L. major [31] and also that
coinjection of dead neutrophils amplified L. major replication in
vivo in BALB [32]. It is tempting to speculate that the rise in
parasite burden observed later on is related to similar effects
exerted by the PMNs recruited following immunization with L.
intermedia saliva and this hypothesis is under current investigation.
In the L. major model, where immunization with P. papatasi SGS
leads to protection against challenge, it is postulated that SGS
immunization precludes the production of type 2 cytokines [8,12].
It was also shown that immunization with SP15, antigen present in
P. papatasi saliva, leads to the development of an anti-saliva DTH
response [14], which was also associated with protection. Herein,
immunization with L. intermedia SGS did not inhibit the production
of type 2 cytokines or promoted the development of a classical
DTH reaction, with the characteristic presence of macrophages
and lymphocytes. Accordingly, immunization with L. intermedia
SGS is favoring L. braziliensis establishment and persistence in
BALB/c mice.
In human visceral leishmaniasis, individuals with positive anti-
Leishmania cellular immune response (a putative marker of
protection against L. chagasi) have increased anti L. longipalpis
saliva IgG levels when compared to individuals with positive anti-
Leishmania humoral immune response (a marker of L. chagasi
infection) [24,27]. In the present study, however, we found an
opposite correlation: a higher anti-L. intermedia saliva immune
response was observed in CL patients whereas individuals from the
endemic area with a positive DTH skin test against Leishmania
Figure 6. IFN-c to IL-4 ratio in BALB/c mice inoculated with L.
intermedia SGS or PBS and challenged with L. braziliensis in the
presence of L. intermedia SGS. Mice were inoculated three times
with PBS or SGS. Two weeks after the last inoculation, mice were
challenged with 10
5 L. braziliensis+SGS (equivalent to 1 pair of salivary
glands/animal). Two, four and 16 weeks post challenge, draining lymph
node cells were collected and stimulated with L. braziliensis+SGS (A) or
with SGS alone (B). Culture supernatants were collected and cytokine
presence was determined by ELISA. The data represent the means and
standard errors of the means from three independent experiments,
each performed with five mice per group.
doi:10.1371/journal.pntd.0000084.g006
Figure 7. Human serum IgG response against SGS. (A) ELISA was
performed against L. intermedia and L. longipalpis SGS using human
sera were from individuals from a CL endemic area (n=100) or from
control individuals (n=10). (B) ELISA was performed against L.
intermedia SGS with human sera from CL individuals (n=16) or from
healthy individuals with either a negative (n=42) or a positive (n=32)
anti-Leishmania DTH skin test. The ordinate represents the absorbance
of the ELISA reaction of these sera against SGS. The symbols indicate
results obtained with each serum tested and lines represent their
median values (***p,0.001).
doi:10.1371/journal.pntd.0000084.g007
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that the detrimental effects of sensitization with L. intermedia saliva
observed in mice have a parallel in individuals exposed in the
endemic area. Rohousosva et al., [29] observed that L. tropica
patients possessed significantly higher anti-P. sergenti saliva IgG
levels when compared to healthy individuals from the same place.
In this work, authors suggested that higher anti-saliva IgG levels
may reflect a more frequent exposure to vector bites and,
therefore, higher probability of L. tropica transmission. In our
study, we also observed a higher anti-L. intermedia SGS humoral
response in individuals from a CL endemic area when compared
to control individuals which may also reflect a more frequent
exposure to vector bites. More importantly, however, we found
that, among individuals from the endemic area, anti-saliva IgG
responses were significantly lower in both DTH+ (individuals who
developed an anti-Leishmania cellular immune response when
exposed to infected sand flies) and in DTH2 (individuals who did
not develop an anti-Leishmania cellular immune response), when
compared to the anti-saliva response in CL patients. It would be
most interesting to determine whether DTH2 individuals either
convert to DTH+ or develop CL and whether the anti-L. intermedia
saliva humoral response, in these cases, increases or decreases,
respectively. Nonetheless, the current results enable us to
hypothesize that, for CL caused by L. braziliensis, a higher anti-
saliva humoral immune response could be used as a marker of risk
for Leishmania transmission, a finding reported for the first time in
New World cutaneous leishmaniasis.
Characterization of the immune response to sand fly saliva has
proven useful in understanding how the molecules present therein
modulate host’s immune response. In the case of P. papatasi and L.
major, a vaccine candidate has been identified and this type of study
now constitutes a major area of research in the development of
control measures against leishmaniasis [26]. However, we have
shown that this is not necessarily applicable to other vector/
parasite systems such as L. braziliensis/L. intermedia. Our study was
conducted with inoculation of SGS and we cannot, presently,
exclude that the effects observed in the mouse model are due to an
immune response against saliva alone and not against a mixture of
saliva and structural components of the salivary gland or even
LPS. Regarding the latter, L. intermedia SGS preparations were
unable to induce TNF-a production following stimulation of
human monocytes (data not shown) and such effect is probably
due to the very low concentrations of LPS (,0.1 ng/ml, below the
detection limit of the Limulus amebocyte assay). Indeed, it would be
very interesting to determine the outcome of L. braziliensis infection
in mice sensitized to L. intermedia sand fly bites. However, rearing of
L. intermedia sand flies under laboratory conditions has proven
a challenging process. To date, there has been very little work on
transmission with L. braziliensis parasites, especially using the sand
fly vectors, and experimental transmission of Viannia parasites by
infected sand fly bite has not been achieved [33]. However, it has
been shown that, regarding the use of SGS, mice develop a strong
DTH response after a double exposure to the equivalent of 0.2
pairs of salivary glands, inoculated intradermally in the ear, and
that a similar cellular infiltrate is mobilized to the skin following
sand fly bites [34]. Moreover, it was also shown that there is little
difference in the composition of sand fly saliva and SGS since
major protein components of SGS are present in the salivary
contents [35], confirming that SGS is an appropriate source of
antigen to mimic natural exposure to sand fly saliva. Nonetheless,
since vector based vaccines are an important alternative envisaging
disease control, we are currently investigating whether immuni-
zation with individual L. intermedia salivary components is capable
of inducing protection.
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